📇 Rhumatologue · PARIS CEDEX 14 · (75) · Salarié
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien-chercheur
13 articles scientifiques publiés — formation continue solide
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
35
35 articles ont été cités au moins 35fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
10 698
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
83
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
48
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Institut Curie
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Prognostic value of early EEG abnormalities in severe stroke patients requiring mechanical ventilation: a pre-planned analysis of the SPICE prospective multicenter study
2024ArticleCritical Care
First‐ever acute ischemic strokes in HIV ‐infected persons: A case–control study from stroke units
2024ArticleAnnals of Clinical and Translational Neurology
Selective Secret Sharing Scheme for Privacy of Image and Video Compressed in MPEG-Like Formats
2023CongrèsMMSP 2023 - IEEE 25th International Workshop on Multimedia Signal Processing
One-Year Outcomes in Patients With Acute Stroke Requiring Mechanical Ventilation
2023ArticleStroke
More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a Stroke
2023ArticleStroke
More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a Stroke
2023ArticleStroke
Successful thrombectomy is beneficial in patients with pre-stroke disability: Results from an international multicenter cohort study
2023ArticleJournal de Neuroradiologie / Journal of Neuroradiology
Recanalization Treatments for Pediatric Acute Ischemic Stroke in France
2022ArticleJAMA Network Open
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CH SAINTE ANNE
1 R CABANIS, 75674 PARIS CEDEX 14
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
The New England journal of medicine · 1996
The Lancet. Neurology · 2011
Epilepsia · 2016
SummaryObjectiveDespite its well‐known effectiveness, the cost‐effectiveness of epilepsy surgery has never been demonstrated in France. We compared cost‐effectiveness between resective surgery and medical therapy in a controlled cohort of adult patients with partial intractable epilepsy.MethodsA prospective cohort of adult patients with surgically remediable and medically intractable partial epilepsy was followed over 5 years in the 15 French centers. Effectiveness was defined as 1 year without a seizure, based on the International League Against Epilepsy (ILAE) classification. Clinical outcomes and direct costs were compared between surgical and medical groups. Long‐term direct costs and effectiveness were extrapolated over the patients’ lifetimes with a Monte‐Carlo simulation using a Markov model, and an incremental cost‐effectiveness ratio (ICER) was computed. Indirect costs were also evaluated.ResultsAmong the 289 enrolled surgery candidates, 207 were operable—119 in the surgical group and 88 in the medical group—65 were not operable and not analyzed here, 7 were finally not eligible, and 10 were not followed. The proportion of patients completely seizure‐free during the last 12 months (ILAE class 1) was 69.0% in the operated group and 12.3% in the medical group during the second year (p < 0.001), and it was respectively 76.8% and 21% during the fifth year (p < 0.001). Direct costs became significantly lower in the surgical group the third year after surgery, as a result of less antiepileptic drug use. The value of the discounted ICER was 10,406 (95% confidence interval [CI] 10,182–10,634) at 2 years and 2,630 (CI 95% 2,549–2,713) at 5 years. Surgery became cost‐effective between 9 and 10 years after surgery, and even earlier if indirect costs were taken into account as well.SignificanceOur study suggests that in addition to being safe and effective, resective surgery of epilepsy is cost‐effective in the medium term. It should therefore be considered earlier in the development of epilepsy.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Neurology · 2020 · Case Reports
Ait Chalal R, Edjlali M, Ben Hassen W, Lamy C, et al.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2016 · Journal Article
Brun JL, Graesslin O, Fauconnier A, Verdon R, et al.
Geriatrie et psychologie neuropsychiatrie du vieillissement · 2013 · English Abstract
Lamy C, Mas JL
Presse medicale (Paris, France : 1983) · 2006 · English Abstract
El-Hage W, Lamy C, Goupille P, Gaillard P, et al.
The New England journal of medicine · 1996 · Journal Article
Hinchey J, Chaves C, Appignani B, Breen J, et al.
Stroke · 2021 · Clinical Trial, Phase II
Pruvost-Robieux E, Benzakoun J, Turc G, Marchi A, et al.
Stroke · 2017 · Journal Article
Yelnik AP, Quintaine V, Andriantsifanetra C, Wannepain M, et al.
The Lancet. Neurology · 2011 · Comparative Study
Stroke · 2013 · Journal Article
Turc G, Apoil M, Naggara O, Calvet D, et al.
Presse medicale (Paris, France : 1983) · 1993 · Case Reports
Assal F, Blanché P, Lamy C, Sicard D, et al.
Stroke · 2017 · Journal Article
Tabone L, Mediamolle N, Bellesme C, Lesage F, et al.
Clinical and experimental rheumatology · 1996 · Case Reports
Blanche P, Lamy C, Zuber M, Sicard D, et al.
Epilepsia · 2016 · Journal Article
Picot MC, Jaussent A, Neveu D, Kahane P, et al.
Chollet F, Tardy J, Albucher JF, Thalamas C, et al.